$163,189,642
to TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE
ABRAMSON CANCER CENTER OF THE U OF P CORE SUPPORT GRANT
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Core support funding for the Abramson Cancer Center at University of Pennsylvania to conduct cancer research and treatment programs.
Large NIH investment in a leading academic cancer research center strengthens U.S. oncology research capacity and clinical innovation.
Supports demand for laboratory equipment, reagents, and specialized medical devices used in cancer research and clinical trials.
Maintains U.S. leadership in cancer research and precision medicine development against international competition in biomedical innovation.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002158.
- 2026-04-22ALZHEIMER'S DISEASE GENETICS CONSORTIUM$60.4M
- 2026-02-27AWARD OF THE BASE TO UPENN FOR CEIRR CONTRACT 75N93021C00015. THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR)$59.3M
- —ARCHES: AUTONOMOUS RESILIENT COGNITIVE HETEROGENEOUS SWARMS$48.5M
- —RESEARCH IN HIGH ENERGY PHYSICS AT THE UNIVERSITY OF PENNSYLVANIA$41.6M
- —PENN PREVENTION CLINICAL TRIALS UNIT$33.0M
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_P30CA016520_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.